Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 11,241Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 9Kalydeco

02 5Orkambi

03 2Symdeko

04 3Symdeko/Symkevi

05 2Trikafta

06 3Trikafta/Kaftrio

PharmaCompass

01

Brand Name : Kalydeco

Ivacaftor

arrow
The Pharmacy Technology
Not Confirmed

Brand Name : Kalydeco

arrow
The Pharmacy Technology
Not Confirmed

Ivacaftor

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2019 Revenue in Millions : 991

2018 Revenue in Millions : 1,008

Growth (%) : -2

blank

02

Brand Name : Symdeko

Ivacaftor

arrow
The Pharmacy Technology
Not Confirmed

Brand Name : Symdeko

arrow
The Pharmacy Technology
Not Confirmed

Ivacaftor

Main Therapeutic Indication : Genetic Disorders

Currency : USD

2019 Revenue in Millions : 1,418

2018 Revenue in Millions : 769

Growth (%) : 84

blank

03

Brand Name : Orkambi

Ivacaftor

arrow
The Pharmacy Technology
Not Confirmed

Brand Name : Orkambi

arrow
The Pharmacy Technology
Not Confirmed

Ivacaftor

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2019 Revenue in Millions : 1,176

2018 Revenue in Millions : 1,262

Growth (%) : -7

blank

04

Brand Name : Trikafta

EleIvacaftor

arrow
The Pharmacy Technology
Not Confirmed

Brand Name : Trikafta

arrow
The Pharmacy Technology
Not Confirmed

EleIvacaftor

Main Therapeutic Indication : Genetic Disorders

Currency : USD

2019 Revenue in Millions : 420

2018 Revenue in Millions : 0

Growth (%) : New launch

blank

05

Brand Name : Symdeko

Ivacaftor

arrow
The Pharmacy Technology
Not Confirmed

Brand Name : Symdeko

arrow
The Pharmacy Technology
Not Confirmed

Ivacaftor

Main Therapeutic Indication : Genetic Disorders

Currency : USD

2020 Revenue in Millions : 629

2019 Revenue in Millions : 1,418

Growth (%) : -56

blank

06

Brand Name : Orkambi

Ivacaftor

arrow
The Pharmacy Technology
Not Confirmed

Brand Name : Orkambi

arrow
The Pharmacy Technology
Not Confirmed

Ivacaftor

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2020 Revenue in Millions : 908

2019 Revenue in Millions : 1,176

Growth (%) : -23

blank

07

Brand Name : Trikafta

Ivacaftor

arrow
The Pharmacy Technology
Not Confirmed

Brand Name : Trikafta

arrow
The Pharmacy Technology
Not Confirmed

Ivacaftor

Main Therapeutic Indication : Genetic Disorders

Currency : USD

2020 Revenue in Millions : 3,864

2019 Revenue in Millions : 420

Growth (%) : 820

blank

08

Brand Name : Kalydeco

Ivacaftor

arrow
The Pharmacy Technology
Not Confirmed

Brand Name : Kalydeco

arrow
The Pharmacy Technology
Not Confirmed

Ivacaftor

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2020 Revenue in Millions : 803

2019 Revenue in Millions : 991

Growth (%) : -19

blank

09

Brand Name : Kalydeco

Ivacaftor

arrow
The Pharmacy Technology
Not Confirmed

Brand Name : Kalydeco

arrow
The Pharmacy Technology
Not Confirmed

Ivacaftor

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2021 Revenue in Millions : 684

2020 Revenue in Millions : 803

Growth (%) : -17

blank

10

Brand Name : Trikafta/Kaftrio

Ivacaftor

arrow
The Pharmacy Technology
Not Confirmed

Brand Name : Trikafta/Kaftrio

arrow
The Pharmacy Technology
Not Confirmed

Ivacaftor

Main Therapeutic Indication : Genetic Disorders

Currency : USD

2021 Revenue in Millions : 5,697

2020 Revenue in Millions : 3,864

Growth (%) : 32

blank